Evaluation of attenuated tumor antigens and the implications for peptide-based cancer vaccine development

Authors

J. S. Berry, Washington University School of Medicine in St. Louis
T. J. Vreeland, Womack Army Medical Center
D. F. Hale, Washington University School of Medicine in St. Louis
D. O. Jackson, Brooke Army Medical Center
A. F. Trappey, Brooke Army Medical Center
J. M. Greene, Brooke Army Medical Center
M. O. Hardin, Madigan Army Medical Center
G. S. Herbert, Brooke Army Medical Center
G. T. Clifton, The University of Texas MD Anderson Cancer Center
G. E. Peoples, Uniformed Services University of the Health Sciences

Journal

Journal of Cancer

Publication Date

2017

Volume

8

Issue

7

Document Type

Open Access Publication

DOI

10.7150/jca.16450

Rights and Permissions

Berry J, Vreeland T, Hale D, Jackson D, Trappey A, Greene J, Hardin M, Herbert G, Clifton G, Peoples G. Evaluation of Attenuated Tumor Antigens and the Implications for Peptide-Based Cancer Vaccine Development. J Cancer 2017; 8(7):1255-1262. doi:10.7150/jca.16450. Available from http://www.jcancer.org/v08p1255.htm

Recommended Citation

Berry, J. S.; Vreeland, T. J.; Hale, D. F.; Jackson, D. O.; Trappey, A. F.; Greene, J. M.; Hardin, M. O.; Herbert, G. S.; Clifton, G. T.; and Peoples, G. E., "Evaluation of attenuated tumor antigens and the implications for peptide-based cancer vaccine development." Journal of Cancer. 8, 7. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/5959